1111 Targeting lipid metabolism to improve PARP inhibitor response in BRCA-associated TNBC

• Geoffrey I Shapiro,
• Jessica Thaxton,
• Anita Mehta,
• Jennifer L Guerriero,
• Adam Nelson,
• Carlos Wagner Wanderley,
• Filipa Lynce,
• Madeline G Townsend,
• Kelly F Zheng,
• Daniel E Michaud,
• Kiran Kurmi,
• Shakchhi Joshi,
• Marcia Haigis

Affiliations

Geoffrey I Shapiro

13Dana-Farber Cancer Institute, Medical Oncology, Boston, USA

Jessica Thaxton

Medical University of South Carolina, Charleston, SC, USA

Anita Mehta

1Brigham and Women’s Hospital, Boston, MA, USA

Jennifer L Guerriero

9Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA, USA

Adam Nelson

Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

Carlos Wagner Wanderley

1Faculdade de Medicina de Ribeirão Preto – Universidade de São Paulo, Ribeirao Preto, Brazil

Filipa Lynce

2Harvard Medical School, Boston, MA, USA

Madeline G Townsend

1Brigham and Woman’s Hospital, Boston, MA, USA

Kelly F Zheng

1Brigham and Woman’s Hospital, Boston, MA, USA

Daniel E Michaud

1Brigham and Women’s Hospital, Boston, MA, USA

Kiran Kurmi

4Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA

Shakchhi Joshi

4Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA

Marcia Haigis

6Brigham and Women’s Hospital, Boston, MA, USA